277 related articles for article (PubMed ID: 31571515)
21. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
[TBL] [Abstract][Full Text] [Related]
22. Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody.
Zou J; Li T; Huang X; Chen S; Guo Q; Bao C
Ann Rheum Dis; 2014 Aug; 73(8):1591-3. PubMed ID: 24739327
[No Abstract] [Full Text] [Related]
23. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy.
Abe Y; Kusaoi M; Tada K; Yamaji K; Tamura N
Rheumatology (Oxford); 2020 Apr; 59(4):767-771. PubMed ID: 31504956
[TBL] [Abstract][Full Text] [Related]
24. Anti-Ro 52 positive dermatomyositis presenting as rapidly progressive interstitial lung disease.
Conway R; O'Donnell R; Fahy R; Doran MF; Cunnane G; O'Shea FD
QJM; 2014 Jul; 107(7):593-4. PubMed ID: 24336848
[No Abstract] [Full Text] [Related]
25. Inverse Gottron's Sign in A Patient With Anti-MDA5 Associated Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.
Lee HJ; Feng A; Huan NC
Am J Med Sci; 2021 Oct; 362(4):e35. PubMed ID: 33582154
[No Abstract] [Full Text] [Related]
26. A case of anti-MDA5 antibody-positive dermatomyositis developing reversible cerebral vasospasm syndrome successfully treated by multi-immunosuppressant combination including mycophenolate mofetil.
Muramatsu T; Tono T; Kanayama Y; Hasegawa Y; Kondo J; Hoshiyama T; Wada T; Arinuma Y; Tanaka S; Yamaoka K
Mod Rheumatol Case Rep; 2021 Jan; 5(1):69-75. PubMed ID: 32811369
[TBL] [Abstract][Full Text] [Related]
27. Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Yoshizaki-Ogawa A; Sato S
J Dermatol; 2020 May; 47(5):483-489. PubMed ID: 32096271
[TBL] [Abstract][Full Text] [Related]
28. A case of simultaneous onset of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis accompanied by interstitial pneumonia and pulmonary tuberculosis.
Fujimoto S; Saito K; Kuwano K
Int J Rheum Dis; 2020 Feb; 23(2):273-275. PubMed ID: 31916372
[No Abstract] [Full Text] [Related]
29. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome.
Tanaka N; Terao C; Nakayama Y; Sasai T; Umezawa N; Yagyu Y; Ito K; Koike R; Nakashima R; Hatta K; Mizoguchi F
Rheumatology (Oxford); 2021 Mar; 60(3):e104-e106. PubMed ID: 33097938
[No Abstract] [Full Text] [Related]
30. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
[TBL] [Abstract][Full Text] [Related]
31. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
32. Three cases of Anti-MDA5 positive dermatomyositis with interstitial lung disease and pneumomediastium.
Figueiredo C; Matos AL; Calvao J; Goncalo M
Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762870
[No Abstract] [Full Text] [Related]
33. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T
Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
35. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E
Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of multi-target therapy in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with early-stage interstitial lung disease.
Suda M; Kataoka Y; Tomishima Y; Jinta T; Rokutanda R; Kishimoto M; Okada M
Scand J Rheumatol; 2017 Nov; 46(6):505-506. PubMed ID: 28649889
[No Abstract] [Full Text] [Related]
37. Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti‑MDA5 antibodies.
Górka J; Szczeklik W; Włudarczyk A; Łoboda P; Chmura Ł; Musiał J
Pol Arch Med Wewn; 2015; 125(9):685-6. PubMed ID: 26200801
[No Abstract] [Full Text] [Related]
38. Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease.
Romero-Bueno F; Diaz Del Campo P; Trallero-Araguás E; Ruiz-Rodríguez JC; Castellvi I; Rodriguez-Nieto MJ; Martínez-Becerra MJ; Sanchez-Pernaute O; Pinal-Fernandez I; Solanich X; Gono T; Gonzalez-Gay MA; Plana MN; Selva-O'Callaghan A;
Semin Arthritis Rheum; 2020 Aug; 50(4):776-790. PubMed ID: 32534273
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.
Hayashi M; Kikuchi T; Takada T
Clin Rheumatol; 2017 Jan; 36(1):239-240. PubMed ID: 27718019
[No Abstract] [Full Text] [Related]
40. Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis.
Peng Y; Zhang S; Zhao Y; Liu Y; Yan B
Clin Rheumatol; 2018 Jan; 37(1):107-115. PubMed ID: 28842784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
